These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6357196)

  • 1. Partial characterization of an endogenous inhibitor of a calcium-dependent form of insulin protease.
    Ryan MP; Duckworth WC
    Biochem Biophys Res Commun; 1983 Oct; 116(1):195-203. PubMed ID: 6357196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification and characterization of insulin protease and its intracellular inhibitor from rat liver.
    McKenzie RA; Burghen GA
    Arch Biochem Biophys; 1984 Mar; 229(2):604-11. PubMed ID: 6367662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of insulin-degrading enzyme from pig skeletal muscle.
    Yokono K; Imamura Y; Shii K; Sakai H; Baba S
    Endocrinology; 1981 Apr; 108(4):1527-32. PubMed ID: 7009152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of an inhibitor of calcium-activated neutral protease from rabbit skeletal muscle.
    Takahashi-Nakamura M; Tsuji S; Suzuki K; Imahori K
    J Biochem; 1981 Dec; 90(6):1583-9. PubMed ID: 6277875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and purification of a Ca2+ ion-activated neutral proteinase inhibitor in rabbit skeletal muscle.
    Cottin P; Azanza JL; Vidalenc P; Ducastaing A; Valin C; Ouali A
    Reprod Nutr Dev (1980); 1981; 21(2):309-17. PubMed ID: 6296943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin degradation by insulin-like growth factors.
    Misbin RI; Almira EC; Duckworth WC; Mehl TD
    Endocrinology; 1983 Oct; 113(4):1525-7. PubMed ID: 6352249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of an inhibitor of calcium-activated neutral protease from rabbit skeletal muscle: purification of 50,000-dalton inhibitor.
    Nakamura M; Inomata M; Hayashi M; Imahori K; Kawashima S
    J Biochem; 1984 Nov; 96(5):1399-407. PubMed ID: 6098576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium dependence of insulin degradation by rat skeletal muscle.
    Ryan MP; Gifford JD; Solomon SS; Duckworth WC
    Endocrinology; 1985 Oct; 117(4):1693-8. PubMed ID: 3928338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of an endogenous 68,000-dalton inhibitor of Ca2+-activated neutral protease from chicken skeletal muscle.
    Ishiura S; Tsuji S; Murofushi H; Suzuki K
    Biochim Biophys Acta; 1982 Feb; 701(2):216-23. PubMed ID: 7041981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and properties of thiol protease inhibitor from rat liver cytosol.
    Hirado M; Iwata D; Niinobe M; Fujii S
    Biochim Biophys Acta; 1981 Jun; 669(1):21-7. PubMed ID: 7028126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
    Duckworth WC; Hamel FG; Bennett R; Ryan MP; Roth RA
    J Biol Chem; 1990 Feb; 265(5):2984-7. PubMed ID: 1689296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin degradation by human skeletal muscle.
    Neal GW; Kitabchi AE
    Biochim Biophys Acta; 1982 Nov; 719(2):259-66. PubMed ID: 6758860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous inhibitor of nonlysosomal high molecular weight protease and calcium-dependent protease.
    Murakami K; Etlinger JD
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7588-92. PubMed ID: 3020549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low-molecular-weight inhibitor of the neutral proteinase from rat intestinal smooth muscle.
    Carney IT; Curtis CG; Kay JK; Birket N
    Biochem J; 1980 Feb; 185(2):423-33. PubMed ID: 7396824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver.
    Ogawa W; Shii K; Yonezawa K; Baba S; Yokono K
    J Biol Chem; 1992 Jan; 267(2):1310-6. PubMed ID: 1730651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
    Harada S; Smith RM; Smith JA; Shah N; Jarett L
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):21-8. PubMed ID: 7864812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway.
    Harada S; Smith RM; Smith JA; Jarett L
    Endocrinology; 1993 Jun; 132(6):2293-8. PubMed ID: 8504733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous thiol proteinase inhibitor from rat liver.
    Kominami E; Wakamatsu N; Katunuma N
    Acta Biol Med Ger; 1982; 41(1):69-74. PubMed ID: 7113549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and some physico-chemical and enzymic properties of a calcium ion-activated neutral proteinase from rabbit skeletal muscle.
    Azanza JL; Raymond J; Robin JM; Cottin P; Ducastaing A
    Biochem J; 1979 Nov; 183(2):339-47. PubMed ID: 534501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.